FDA Orange Book · active-ingredient family
Rose bengal sodium i-131
Rose bengal sodium i-131 is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ROBENGATOPE · NDA 016224
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ROBENGATOPE×3 | BRACCO | NDA 016224 | — | Approved Prior to Jan 1, 1982 | |
| SODIUM ROSE BENGAL I 131 | SORIN | NDA 017318 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Rose bengal sodium i-131 — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

